News

Video

CURE's Top Stories: February 2020

Here are the top five CURE® stories for February 2020.

Here are the top five CURE® stories for February 2020.

5. “I Never Met Frederic Mohs”

In this reader-submitted story, a skin cancer survivor shares his experience with squamous and basal cell carcinoma — and the healthy-tissue-sparing surgery that removed those cancerous cells and has him back to living life to the fullest.

4. Understanding Prevention For Hereditary Cancer

In honor of National Cancer Prevention Month, we take an in-depth look at how knowledge is power when it comes to hereditary cancers, in this piece.

3. Just Remember Not to Stop

Here, a cancer survivor laments not getting more done until she realizes that she just moves slower, and that's OK. As long as you don't stop.

2. New Blood Test Could Detect Cancer Cells

In this story, we look at a new study that supports the use of a blood test to detect clusters of cancer cells in the blood of asymptomatic individuals, potentially giving patients a non-invasive screening and testing method.

1. Finding Purpose After Five Different Cancers

In this episode of the “CURE Talks Cancer” podcast, we spoke with Lainie Jones, who found her purpose in helping others after being diagnosed with five separate primary cancers before the age of 35 because of Li-Fraumeni syndrome, a rare genetic condition that predisposes her to develop the disease.

Related Videos
Image of bald man.
Dr. Tycel Phillips is an Associate Professor in the Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope in Duarte, California.
Image of Dr. Salani.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.
Image of Dr. Fakih.
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.